Table 1.
Baseline characteristics of study participants, MESA 2000-2002
| Women | Men | |
|---|---|---|
| N | 2,737 | 3,130 |
| Age, years | 65 (9) | 62 (10) |
| Race/ethnicity | ||
| White | 1,048 (38%) | 1,228 (39%) |
| Chinese American | 342 (13%) | 387 (12%) |
| Black | 737 (27%) | 801 (26%) |
| Hispanic | 610 (22%) | 714 (23%) |
| Education | ||
| <Bachelor’s degree | 1,966 (72%) | 1,841 (59%) |
| ≥Bachelor’s degree | 771 (28%) | 1,289 (41%) |
| Physical activity, MET-min/wk | 3,510 (1,710-6,435) | 4,470 (2,175-8,490) |
| Smoking status | ||
| Current smoker | 287 (10%) | 449 (14%) |
| Former smoker | 824 (30%) | 1,406 (45%) |
| Never smoker | 1,626 (59%) | 1,275 (41%) |
| Pack-years of smoking if >0 | 15 (6-31) | 18 (7-35) |
| BMI, kg/m2 | 29 (6) | 28 (4) |
| Health insurance | ||
| Yes | 2,507 (92%) | 2,851 (91%) |
| No | 230 (8%) | 279 (9%) |
| Systolic blood pressure, mmHg | 129 (24) | 126 (19) |
| Total cholesterol, mg/dL | 202 (36) | 188 (35) |
| HDL-cholesterol, mg/dL | 57 (15) | 45 (12) |
| Diabetes mellitus | 338 (12%) | 429 (14%) |
| eGFR, ml/min per 1.73m2 | 75 (16) | 78 (16) |
| Use of antihypertensive medication | 1,147 (42%) | 1,114 (36%) |
| Use of lipid-lowering medication | 522 (19%) | 511 (16%) |
| Total T (nmol/L) | 0.9 (0.6-1.3) | 14.2 (11.3-17.8) |
| Free T (%) | 1.3 (0.9-1.7) | 2.0 (1.7-2.3) |
| Estradiol (nmol/L) | 0.07 (0.05-0.15) | 0.11 (0.09-0.14) |
| DHEA (nmol/L) | 10.2 (6.9-14.5) | 12.5 (9.1-17.1) |
| SHBG (nmol/L) | 59.7 (40.6-93.9) | 40.8 (31.4-52.6) |
BMI, Body mass index; CT, Computed tomography; eGFR, Estimated glomerular filtration rate; DHEA, Dehydroepiandrosterone; HDL; High density lipoprotein; MESA, Multi-Ethnic Study of Atherosclerosis; MET-min/wk, Metabolic equivalent of task-minutes/week; SHBG, Sex hormone binding globulin; T, Testosterone.
Data were presented as mean (SD) for normally distributed variables, median (IQR) for skewed variables and count (percentage) for categorical variables.